Remegal Different Doses in Patients With Refractory Partial Seizures

Clinical trial NCT01179854 · COMPLETED

Trial details

NCT number: NCT01179854
Sponsor: Valexfarm
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Drug Safety Normal Drug Tolerance Self Efficacy

Start date: 2009-09-01
Primary completion: 2010-11-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.